Acted as a Rule 3 Adviser, Financial Adviser and Broker to Diurnal Group PLC
Panmure Gordon was delighted to act as a Rule 3 Adviser, Financial Adviser and Broker to Diurnal Group PLC for the recommended cash acquisition by Neurocrine Biosciences for c.£48m.
Panmure Gordon’s team included: Freddy Crossley, Emma Earl, Rupert Dearden and Mark Rogers.
Managing Director, Head of Healthcare
Managing Director, Healthcare, Investment Banking
Managing Director, Corporate Broking Services